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1, INTRUDUCTION 
tnsulin and the insulin-like growth factors. I und II 
(IGF-I and IGF-II) arc structurally r&ted hormones 
with a similar spectrum of biologicrrl nctivitius [ 1.21, In 
general. though, insulin is more potent as u stimulator 
of anubolic pilthways. whcrcus the IGFs arc fur more 
efficient in stimulatingcell proliferation and diffcrcntiu- 
cion, Nearly ull the IGFs in the bloodstream arc dcrivcd 
from the liver and arc arsociiltcd with inhibitory binding 
proteins. howcvcr, the IGFs arc also synthcsizcd in 
nearly all other tissues, whcrc they Serve on autocrinc/ 
parncrinc function. There arc distinct receptors for insu- 
Iii;, IGF-I and IGF-II on thr plnsmo mcmbmne. but 
their specificity is not absolute. cxccpt for the lack of 
binding of insulin to the IGF-II receptor [2]. Signal 
trrlnsduction by the IGF-I and insulin receptors probn- 
bly involves activation of the tyrosinc kinasc activity of 
their fl-subunit. The molecular function of the IGF-II 
receptor is still unknown. 
Orthovanadatc (VQr~j, mctavanadutc (YO,‘), and 
vanadyl compounds (VOX*) mimic several cffccts of in- 
sulin [3] when administered in vivo 141 or rrddcd to iso- 
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lt\tcd ;Idipocytcs [5-O]. Many ultcrutions in insulindc- 
pcndcnt and non-insulin-dependent diabetes. including 
hypcrglycacmia and deficient glucose trungport and gly= 
cogen synthesis. can also bc corrcctcd by chronic ora1 
itdministrzrtion of vunadutc or vzlnudyl salts [3,10-151. 
The cxtlct mcchuniam of thcsc insulin-like effects still 
remains unclear [I§]. Earlier dnttl indicated that van+ 
date stimulated the uutophosphorylution and the tyro- 
sine kinouc activity of the insulin receptor [6]. Howcvcr, 
it has become clcnr that vonadotc an bypass the insulin 
receptor. Thus, inscllin-like cffccts huvc been obtuincd 
tit conccntmtions of vnnndntc that do not effect the 
tyrosinc kintisc astivity or the phosphorylation stutc of 
the insulin rcscptor [4,7,14], Also, the cffcicncy of ~an;l- 
date in stimulating lucose traneport appears to bc indc- 
pcndcnt of the number of insulin receptors in the plasma 
membrane [$I. Further, vunodutc does not exactly 
mimic alI the cffccts of insulin in vitro [9.16-181. In 
isolated hcptitocytcs, it can cvcn produce effects oppo- 
site to insulin [19]. An exception should probably be 
made for peroaovunadatcs (fcxmcd by reaction of 
orthovunadate with H$&) which huvc full insulin-like 
cffccts, perhaps via activation of (11s insulin-receptor 
tyrosinc kinusc [I&20]. 
WC report here the results of a compslmtivc study of 
the effects of vanitdatc and insulin on glycogcn synthesis 
in vivo and in vitro. It appears that the stimulatory 
effect of vanadatc, in diaphragm and probably also in 
her, is indircti but iiai iiiie&air”u Gy ihZ Ii&h s*it!= 
ing pathway. Our results suacst a mediatory role of 
IGFs. 
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2. EXFERlMENTAL 
Human recombinant insulin (humulin rcgulnr) wus obtuincd from 
Eli Lilly. Hum&m rccombinan; IGF-I ttnd IGF-11 wcrc gills from 
CibaGciyy (&scl, Switzcsrlnnd) and Eli Lilly (lndianrrprrlh. IN, 
USA). rcrpcctkcly. Na)YO, was purrhvwd from Fisher Seictatific und 
R-(U~“CJplucor from Amcrsham. 
Ovcrnisht-fasted fcmnlc Wirlnr rntr af about 100 0 were injected 
intrapcritottcally with OS mI rulinc containin 2 )rCi of [“Cj&tcosc 
only, or plus cithsr 6.5 #mol of Nn,YO, or 0. I nmcl of ingulin. AiIcr 
5. 20. 50 or 110 min. % tng of radium psnrobarbitnl war injcctcd 
intnpcritoncally, 10 min later tbcabdomcn wasapn& \nd blood WM 
collected from the portal vein in an hcpsrinized tube. Then the liver. 
the diaphragm. snd the heart wcrc succc%ivcly isolated end nt once 
froxcn in liquid N,. A frugncnt wan later wcigttcd and dropped in 2 
vol. of B solution contuinina I M NeOH and 1% (w/v) shcllftsh &co- 
gcn. which wus hriltcd for 30 min at 90% 
Thcsc wcrc prcprrcd with purl of the rib cqc ;rttxhcd from nor- 
mally fed fcmelc Wistnr rnts of 60-80 g [?I], They wcrc flrrt prc- 
incubated for 2x I5 min II 37% in I? nil (diaphragms) or 6 ml 
(hcmidinphrqms) of Krcb’s-&n&it bictrbamrtc buffer plus 5 mM 
plucosc. Subscqucntly. the (hc:ni)diophr;rpms w%rc incubutcd in hnlf 
the previous volume of the same medium. with ar without vonndatc 
(I mM unless stated othcrwisc), ;md [“C]glurarc and harmancr were 
nddd ttr indientcd, After IO-60 min the (hcmi)dinphrugnrs wcrc iro- 
Iatcd from the rtrtlrhcd ribs. wciQltcd and diwtcd ;rrdcrrrlbed ebovr. 
For the dctcrminntion of [‘Qlpogrn. I5OpI of the NaOH digest 
wns spotted onto filter paper (Whatman ET31). which was warhsd 4 
x 20 min in 66% (v/v) cthtmal. The papers wcrc then washed onsc in 
IICC~ORC. dried and counted. Plasma gh~co~c was nraaycd by the ght- 
cost oxidasc method [22]. Insulin. IGF-I and fGF-II wcrc mcururcd 
by radioimmunoitssays, The antibodies us& wcrc n polyclonnl auinca 
pip nntircrum against rccombinnnt humnn IGF-I [23] und n monocle- 
nrl mow anti-IGF-lf (Strr-Lab, Suw. UK). Plnrmu binding pro- 
teins wcrc removed by trcntmcnt with acid ethanol and lrcid iIcctonc. 
rcspcctivcly. for the ICiF-1 nnd lCiF41 a6sayn. It waschcckcd with 20 
samples that near-idcntirul rcsultr wcrc obtained when the IGFr wcrc 
scpu~tcd from lhcir binding proteins by gel filtrulion an Supsrdcx in 
ttn ucid medium us dcseribcd in (24). 
The rcarltr urc yivcn as mcuns + S.E.M. for the indictttcd number 
01) of observations. Stntistintl trcatmcnt was by Student’s r=test for 
unpilircd dutn. 
3, REWJLTS 
Thirty minutes after t\n intropcritoncal co-injcccion of 
insulin and [“C]glucosc into rats. the amount of label 
incorporated into diaphrqmnl glycqcn was 22-times 
higher than in the control condition (Table I). Ninety 
minutes lacer the amount of lab&d glycogcn had aS;iin 
insrcascd fourfold in the diaphragm of chc insulin- 
treated animals. in spite of the dcsrcasing specific radio= 
xtivity of the plasma glusosc. However. insulin failed 
to stimulutc glycogcn synthesis in liver und heart within 
the 2-h observation period, The incorporation of &.I- 
cost into &co&m in the diaphragm was also stimulutcd 
by an injection of vanudntc. This effect wtls already 
significant after 15 min and chc labs1 concinucd co be 
rapidly incorporated into glycogen for up CO 2 h. when 
the amount of radioactive glycogen reached 40% of chat 
dcpoaitcd after insulin trdministrotion. Vunadotc also 
atimulatcd by about IO-fold the incorporation of labs1 
from [W]glucosc into glycogcn in hrurt tend liver. us 
msasurcd after 1 h and 2 h. rcspcctivcly. 
The administration of vanadirtc aused a significant 
hypoglycacmio (-20%) after IS min. which hud turned 
into a mild hypcrglycacmin (+20%) by 60 min (Table 
II). Howcvcr. vanadnce did not affect the circulating 
concentrations of insulin or of IGF-1. Adult rats have 
very little circulating IGF-II [2], irnd the detection lcvcl 
was not rcachcd 15 min and 60 min after the administru- 
tion of vantrdacc (not illustracccl). 
In view of the marked in vivo effects of vanndocc and 
Tnblc I 
Effect of sn intnpcritoncnl injcctian of insulin or venadatc on the incorporation of label from [“C]glucorc into glycogcn in various rat tissues 
Tissue Period of trcatmcnt (min) Glucorc incorporntcd into ylycogn (cpntinrg of tirruc) 
Snlinc Insulhi Vanndatc 
Diaphragm 
:: 
1.2+0,2 (5) 4.6+0.8 (5)’ 
I .7t0,4 (5) 37.25 12.9 (5)’ 7.5*3,1 (5)’ 
60 2.9f0.9 (14) 20.2+3.4 (16)’ 
I20 s.s+1.1 (5) 161 sOi9.6 (4)’ 64&&O (5)’ 
Heart 30 I .5to,2 (5) I ,7fO. I (5) I .l?rO. I (5) 
60 1*ot0,3 (14) 10,7+1.5 (16)’ 
120 I -7f0.3 (5) 1.6iO.2 (5) 11.411.5 (5)’ 
tivcr 3G 3.8+0.9 i5j Is,wLa (5j 5.3ki.4 iSi 
60 l.tt~0,3 (14) 3.0t0.4 (16)’ 
120 3.8+O,S (5) 2,2?0.4 (5) 31.3t4.0 (5)’ 
The dctuils of the cxpcrimcnt arc described in section 2. *P C 0.01 VP. sillinc-trc;ltcd. 
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Fig. 1. The ctlktr of insulin, IGF-I or IGF-II. without or with vane 
dn~c, on the rate of glycogcn rynrhcsis in isolutcd (hcnti)diuphgrnmr, 
(A) Ncmidiaphgrttgms H’CFE incubutsd for 1 Ir in 3 ml of medium with 
5 mtvi ~lucosc plur or minus 1 mM Nn,YO,. After 50 min, 2gZi of 
[“C~glucor wcrc added plus the indic;ltcd conscntrations of insulin. 
and the hcmidiaphmymr wcrc removed 10 min lutcr. (13 und C) Entire 
diaphrtlgrnr wcrc incubutcd for I h in 6 ml ol’ medium contuining 5 
mM (4 yCi) [“C]glucoss. with or without 1 mM Nn,VO,. nnd the 
indicated conccnlmtions ol’ IGF-I or IGF-Il. Vcrlical bars rcprcscnt 
+S.E.M. The number ol’obscrvtitionr is indicated bctwccn prircnthcses 
UI the bowm ol+cwh column. lfJ 5 0.04 vs, ubwcc ofvunndatc; ‘P 
s 0.012 YE. ilbscncc or hornronc, 
insulin on the diaphragm, we have also compared their 
capacity to srimuiatc giycogcn synfhcsis iri iScik& 
hcrnidiaphragms, While an exposure in vitro to 1.8 nM 
and 600 nM insulin for 10 min increased the insorpora- 
tion of lab&d glusos~ into glycogcn f-fold and 7-fold, 
rcspsctivcly (Fig. IA), the prcscncc of 1 mM vanadstc 
for 1 h did not affect the lobcling of glycogcn (Fig, 
1 A,B,C: P = Q,O6: I) = 1 S). lower (0.1 mM) or higher 
(5 mM) conccntrirtions of vanedatc for 104 min WCTC 
ulso incffcctivc (not illnstraxd), Neither did the pres- 
cncc of 1 mM vmrdatc modify the cff’kt ofcithcr insu- 
lin concentration (Fig. 1A). 
Fig. 1 illustrutcs also the results of experiments with 
two concentrations of IGF-I (panel B) and IGF-II 
(panel C). Ncithcr concentration of IGF-I caused a sig- 
nilisant inrrcnsc in glysopn synthesis, but in the prcs- 
cncc of I mM vanadatc the rate was incrcwsd 2.3.fold 
and 60fold by 6,7 nM and 26.7 nM IGF-1, rcspsstivcly. 
A quolitativcly similar pattern was noted for IGF-II. 
but here P significant synergism with vunadatc rquircd 
26.7 nM IGF-II, which by itsslf doubled the rate of 
glycogcn synthesis. 
4, i3SCUSSION 
Sodium orthovanadatc only stimulated thr incorpo- 
rtrtion of [“C]glucosc into diaphragmal glycogcn when 
it was udministcrcd in vivo (Fig. 1; Table I). This agrees 
with reports that orthovanudutc iso very wcok stimuls- 
tar of glycogen synthesis when added to skclctal muscle 
prcpltrations in vitro [l&18], Morcovcr. WC have found 
that wnudittc incrcass hcpntic glycogsn synthesis in 
vivo (Table I). whcrclls it dots not mimic the stimula- 
tory efkct of insulin on glycogcn synthesis in cultured 
E-kg-G2 cells (unpublished ata). Rodriguez-Gil et tt!. 
[I91 observed that vstnadntc even ~uscs slycogcnolytic 
changes in isolated hcpatucytcs. Taken together. thcsc 
data indicate that the glycogsnis cffcst of vanadatc xc- 
quircs, at lcast in some tissues. a fastor thrrt is absent 
during incubation in vitro. 
Our results eliminated insulin as a candidate for such 
u factor. Indeed, vanadutc did not incrcrrsc the plusma 
insulin level (Table II) and it did not cnhancc the action 
of insulin on the isolated diaphragm (Fig. IA). In fact. 
our data arc in keeping with the cmcrging conclusion 
that many metabolic effects of vanadacc arc not medi- 
ated by the insulin receptor (see Introduction). 
It is noteworthy that in our studies in viva the action 
of insulin was limited to the diaphragm, whcrcas vana- 
Table II 
Concentrations or glucose, insulin and SF-1 in the portal p rrsma at 
the indiwtod times after an intrqxxitoncal injection of ven;ldatc 
Yenadrrtc 
trcatmcnt 
Glucesc (mM) Insulin (PM) fGE-f (nM1 
3&n 5.feo.1 fl0) 148217 (15) 8224 !8) 
I5 min 4.0+0.2 (5) lot+?4 (5) 9928 (IO) 
60 rnin Is.o+o.4 (5)’ 17&!z17 (14) 8&S cat, 
‘P < 0,001, l 0‘05 VY, 0 min. 
Yolun~c 3OY, number 2 FEES LETTERS 
date affected liver, diaphragm and heart (Table I). 
There is u striking parallcl between these observations 
and the results of Jacob ct al. [25] who studied the 
incorporation of lobclcd glucose into tissue glycopn in 
rats during a 3-h cuglycacmic lamp while either insulin 
or LGF-I was infused; they found that IGF-I stimulated 
glycogcn synthesis not only in sbclcral musslc, but also 
in tissues where glycogcn synthesis was not (liver) nf- 
fcctcd or was ncgativcly (heart) aft&cd by insulin. 
Thcsc striking similnritics prompted us to consider 
whether IGF-I could be the factor required far the ac- 
tion of vanadatc in vivo. The marked synergism bc- 
twccn vanadtttc and tGF-1 in vitro (Fig. I B) is in agrcc- 
rncnt with this hypothesis. Vunudatc also potcntiatcd 
the action of IGF-II (Fig. IC), This may seem irrelevant 
in view of the very low cirsuloting lcvcls of IGF-II in 
adult rats. but it has been pointed out that the rat is 
rather the exception in this regard [Z], 
Further experiments will be required to see whether 
the putative mediatory role of IGF4 also applies to 
other metabolic ffccts of vonadatc. It also remains to 
be established how vunadate nmplitics the action of 
IGF-I on glycogcn synthesis in isolated diaphragms, 
Among the p~ssibilirics arc an increased binding cfft- 
cicncy or capacity for IGF-I. and an incrcascd tyrosinc 
kinasc activity of the @-subunit of the IGF-I receptor. 
Vanadate increases the number of IGF-II receptors, at 
least on adipocytcs [26], Finally, it b tempting CO spccu- 
late on a role of IGF-I in the long-term effects of vana- 
date in diabetes [3.10-l 51. 
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